Author Archives: jascally

The FDA’s Vaccines and Related Biological Products Advisory Committee

for attentives only … almost 9 hours long ! The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.